Childhood Acute Lymphoblastic Leukemia: Is There a Tumor Suppressor Gene in Chromosome 12p 12.3 ?

References

• Greaves M. A natural history for pediatric acute leukemia. Blood 1993; 82: 1043–1051
   PubMed Web of Science ®Google Scholar
• Lococo F., Saglio G. Single or multiple origin of hemopoietic tumors: the contribution of clonality studies. Leukemia 1995; 9: 1586–1589
   PubMedGoogle Scholar
• Weinberg R. A. Oncogenes, anti-oncogenes, and the molecular basis of multistep carcinogenesis. Cancer Research 1989; 49: 3713–3721
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Kinzler K. W. The multistep nature of cancer. Trends in Genetics 1993; 9: 138–141
   PubMed Web of Science ®Google Scholar
• Cleary M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cell 1991; 67: 619–622
   Web of Science ®Google Scholar
• Rabbitts T. H. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991; 67: 641–644
   PubMed Web of Science ®Google Scholar
• Rabbitts T. H. Chromosomal translocations in human cancer. Nature 1994; 372: 143–149
   PubMed Web of Science ®Google Scholar
• Prigogina E. L., Puchkova G. P., Mayakova S. A. Nonrandom chromosomal abnormalities in acute lymphoblastic leukemia of childhood. Cancer Genetics and Cytogenetics 1988; 32: 183–203
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes and Cancer 1993; 8: 205–218
   PubMed Web of Science ®Google Scholar
• Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic. Blood 1993; 81: 2237–2251
   PubMed Web of Science ®Google Scholar
• Champlin R., Gale R. P. Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 1989; 73: 2051–2066
   PubMed Web of Science ®Google Scholar
• Cayuela J. M., Madani A., Sanhes L., Stem M. H., Sigaux F. Multiple tumor- suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 1996; 87: 2180–2186
   PubMed Web of Science ®Google Scholar
• Chen Y. C., Chen P. J., Yeh S. H., Tien H. F., Wang C. H., Tang J. L., Hong R. L. Deletion of the human ret-inoblastoma gene in primary leukemias. Blood 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Schottelius A., Brennscheidt U., Ludwig W. D., Mertels-Mann R. H., Herrmann F., Lubbert M. Mechanisms of p53 alteration in acute leukemias. Leukemia 1994; 8: 1673–1681
   PubMed Web of Science ®Google Scholar
• Berger R., Bemheim A., Leconiat M., Vecchione D., Pacot A., Daniel M., And T., Flandrin G. Abnormalities of the short arm of the chromosome 12 in acute non-lymphoblastic leukemia and dysmyelopoietic syndrome. Cancer Genetics and Cytogenetics 1986; 19: 281–289
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Wiliams D. L., Callihan T., Peiper S., Rivera G. K., Murphy S. B. Nonrandom involvement of 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69–75
   PubMed Web of Science ®Google Scholar
• Mitelman F. Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. S. Karger AG., Basel, Switzerland 1991
   Google Scholar
• Chan L. C., Kwong Y. L., Liu H. W., Lee C. P., Chan A. Y. Y. Deletion 12p in de novo acute myeloid leukemia (an association with early progenitor cell). Cancer Genetics and Cytogenetics 1992; 62: 47–49
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Bartram C. R., Wada M., Reiter A., Hatta Y., Seriu T., Lee E., Miller C. W., Miyoshi I., Koeffler H. P. Allelotype analysis of childhood acute lymphoblastic leukemia. Cancer Research 1995; 55: 5377–5382
   PubMed Web of Science ®Google Scholar
• CavÉ H., Guidal C., Elion J., Vilmer E., Grandchamp B. A low rate of loss of heterozygosity is found at many different loci in childhood B-lineage acute lymphocytic leukemia. Leukemia 1996; 10: 1486–1491
   PubMed Web of Science ®Google Scholar
• Baccichet A., Qualman S. K., Sinnett D. Allelic loss in childhood acute lymphoblastic leukemia. Leukemia Research 1997a; 21: 817–823
   PubMed Web of Science ®Google Scholar
• Knudson A. G. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Science USA 1971; 68: 820–823
   PubMed Web of Science ®Google Scholar
• Stegmaier K., Pendse S., Barker G. F., Bray-Ward P., Ward D. C., Montgomery K. T., Krauter K. S., Reynolds C., Sklar J., Donnelly M., Bohlander S. K., Rowley J. D., Sallan S. E., Gilliland D. G., Golub T. R. Frequent loss of heterozygosity at the EL gene locus in acute lymphoblastic leukemia in childhood. Blood 1995; 86: 38–44
   PubMed Web of Science ®Google Scholar
• Sato Y., Suto Y., Pietenpol J., Golub T. R., Gilliland D. G., Davis E. M., Lebeau M. M., Roberts J. M., Vogelstein B., Rowley J. D., Bohlander S. K. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525–1533
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Bartram C. R., Miller C. W., Reiter A., Seriu T., Zimmermann M., Schrappe M., Mori N., Slater J., Miyoshi I., Koeffler H. P. Acute lymphoblastic leukemia of childhood: Identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996a; 87: 3368–3374
   PubMed Web of Science ®Google Scholar
• Baccichet A., Sinnett D. Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukemia. British Journal of Haematology 1997b; 99: 107–114
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Montgomery K. T., Bohlander S. K., Adra C. N., Lim B. L., Kucherlapati R. S., Donis-Keller H., Holt M. S., Le Beau, And M. M., Rowley J. D. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood 1994; 84: 3473–3482
   PubMed Web of Science ®Google Scholar
• Kucherlapati R., Marynen P., Turc-Carel C. Report of the fourth international workshop on human chromosome 12 mapping 1997. Cytogenetics and Cell Genetics 1997; 78: 81–95
   Google Scholar
• Polyak K., Lee M. H., Erdjument-Bromage H., Koff A., Roberts J. M., Tempst P., Massagui J. Cloning of p27KIO1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78: 59–66
   PubMed Web of Science ®Google Scholar
• Toyoshima H., Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67–74
   PubMed Web of Science ®Google Scholar
• Krauter K., Montgomery K., Yoon S. J., Leblanc-Straceski J., Renault B., Marondel I., Herdman V., Cupelli L., Banks A., Lieman J., Menninger I., Bray-Ward P., Nad-Kami P., Weissenbach J., Le Paslier D., Rigault P., Chuma-Kov I., Cohen D., Miller P., Ward D., Kucherlapati R. A second-generation YAC contig map of human chromosome 12. Nature 1995; 377(supp.)321–333
   PubMedGoogle Scholar
• Hudson T. J., Stein L. D., Gerety S. S., Ma J., Castle A. B., Silva J., Slonim D. K., Baptista R., Kruglyak L., Xu S.-H., Hu X., Colbert A. M. E., Rosenberg C., Reeve-Daly M. P., Rozen S., Hui L., Wu X., Vestergaard C., Wilson K. M., Bae J. S., Maitra S., Ganiatsas S., Evans C. A., Dean-Gelis M. M., Ingalls K. A., Nahf R. W., Horton L. T., Jr., Oskin Anderson M., Collymore A. J., Ye W., Kouyoum-Ijian V., Zemsteva J. S., Tam J., Devine R., Courtney D. F., Turner Renaud M., Nguyen H., Oconnor T. J., Fizames C., FaurÉ S., Gyapay G., Dib C., Morissette J., Orlin J. B., Birren B. W., Goodman N., Weissenbach J., Hawkins T. L., Foote S., Page D. C., Lander E. S. An STS-based map of the human genome. Science 1995; 270: 1945–1954
   PubMed Web of Science ®Google Scholar
• Pietenpol J. A., Bohlander S. K., Sato Y., Papadopoulos N., Liu B., Friedman C., Trask B. J., Roberts J. M., Kin-Zler K. W., Rowley J. D., Vogelstein B. Assignment of the human p27KIP1 gene to 12∼13 and its analysis in leukemias. Cancer Research 1995; 55: 1206–1210
   PubMed Web of Science ®Google Scholar
• Ponce-Castaneda M. V., Lee M. H., Latres E., Polyak K., Lacombe L., Montgomery K., Mathew S., Krauter K., Sheinfeld J., Massague J., Cordon-Cardo C. p27KIP1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Research 1995; 55: 1211–1214
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker G. F., Lovett M., Gilliland D. G. Fusion of PDGF receptor beta to a novel ETS-like gene, TEL, in chronic myelomonocytic leukemia with t(5, 12) chromosomal translocation. Cell 1994; 77: 307–316
   PubMed Web of Science ®Google Scholar
• Golub T. R., McLean T., Stegmaier K., Carroll M., Tomas-Son M., Gilliland D. G. The TEL gene and human leukemia. Biochimica et Biophysica Acta 1996; 1288, M7–M10.
   Google Scholar
• Buijs A., Sherr S., Van Baal S., Van Bezouw S., Van Der Plas D., Van Kessel A. G., Riegman P., Lekanne Deprez R., Zwarthoff E., Hagemeijer A., Grosveld G. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN gene on 22q11. Oncogene 1995; 10: 1511–1519
   PubMed Web of Science ®Google Scholar
• Peeters P., Wlodarska I., Baens M., Criel A., Selleslag D., Hagemeijer A., Van Den Berghe H., Marynen P. Fusion of ETV6 to MDS1/EV11 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Research 1997; 57: 564–569
   PubMed Web of Science ®Google Scholar
• Papadopoulos P., Ridge S. A., Boucher C. A., Stocking C., Wiedernann L. M. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Research 1995; 55: 34–38
   PubMed Web of Science ®Google Scholar
• Wlodarska I., Mecucci C., Marynen P., Guo C., Franckx D., Lastarza R., Aventin A., Bosly A., Martelli M. F., Cassiman J. J., Van Den Berghe H. TEL gene is involved in Myelodysplastic Syndromes with either the typical t(5;12)(q33;p13) translocations or its variant t(10;12)(q24;p13). Blood 1995; 85: 2848–2852
   PubMed Web of Science ®Google Scholar
• Golub T. R., Barker G. F., Bohlander S. K., Hiebert S. W., Ward D. C., Bray-Ward P., Morgan E., Raimondi S. C., Rowley J. D., Gilliland D. G. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Science USA 1995; 92: 4917–4921
   PubMed Web of Science ®Google Scholar
• Shurtleff S. A., Buijs A., Behm F. G., Rubnitz J. E., Raimondi S. C., Hancock M. L., Chan G. C. F., Pui C.-H., Grosveld G., Downing J. R. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989
   PubMed Web of Science ®Google Scholar
• Romana S. P., Poirel H., Leconiat M., Flexor M. A., MauchauffÉ M., Jonveaux P., Macintyre E. A., Berger R., Bernard J. A. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263–4269
   PubMed Web of Science ®Google Scholar
• Raynaud S., Mauvieux L., Cayuela J. M., Bastard C., Bilhou-Nabera C., Debuire B., Bones D., Boucheix C., Char-Rin C., FiÈRe D., Gabert J. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia. Leukemia 1996a; 10: 1529–1530
   PubMed Web of Science ®Google Scholar
• Shih L.-Y., Chou T.-B., Liang D.-C., Tzeng Y.-S., Rubnitz J. E., Downing J. R., Pui C.-H. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan. Leukemia 1996; 10: 1456–1458
   PubMed Web of Science ®Google Scholar
• Loh M. L., McLean T. W., Buckley J. D., Howells W., Gilliland D. G., Smith F. O. Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEWAML1. Leukemia Research 1998; 22: 461–464
   PubMed Web of Science ®Google Scholar
• Rubnitz J. E., Shuster J. J., Land V. J., Link M. P., Pullen D. J., Camitta B. M., Pui C.-H., Downing J. R., Behm F. G. Case-control study suggests a favorable impact of “EL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: A pediatric oncology group study. Blood 1997; 89: 1143–1146
   PubMed Web of Science ®Google Scholar
• McLean T. W., Ringold S., Neuberg D., Stegmaier K., Tantravahi R., Ritz J., Koeffler H. P., Takeuchi S., Janssen J. W. G., Sen T., Bartram C. R., Sallan S. E., Gilliland D. G., Golub T. R. TELIAML-1 dimerizes and is associated with a favorable outcome in childhood acute lym-phoblastic leukemia. Blood 1996; 88: 4252–4258
   PubMed Web of Science ®Google Scholar
• Lanza C., Volpe G., Basso G., Gottardi E., Barisone E., Spinelli M., Ricotti E., Cilli V, Perfetto F., Madon E., Saglio G. Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. British Journal of Haematology 1997; 97: 460–162
   PubMed Web of Science ®Google Scholar
• Harbott J., Viehmann S., Borkardt A., Henze G., Lampert F. Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933–4937
   PubMed Web of Science ®Google Scholar
• Leconiat M., Della Valle V., Marynen P., Berger R. A new breakpoint, telomeric to TEL/ETV6, on the short arm of chromosome 12 in T cell acute lymphoblastic leukemia. Leukemia 1997; 11: 1360–1363
   PubMed Web of Science ®Google Scholar
• Sato Y., Bohlander S. K., Kobayashi H., Reshmi S., Suto Y., Davis E. M., Espinosa R., III, Hoopes R., Montgomery K. T., Kucherlapati R. S., Lebeau M. M., Rowley J. D. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half. Blood 1997; 90: 4886–4893
   PubMed Web of Science ®Google Scholar
• Crepieux P., Coll J., Stehelin D. The ets family of proteins: weak modulators of gene expression in quest for transcriptional partners. Critical Reviews in Uncogenesis 1994; 5: 615–638
   PubMed Web of Science ®Google Scholar
• Raynaud S., CavÉ H., Baens M., Bastard C., Cacheux V., Grosgeorge J., Guidal-Giroux C., Guo C., Vilmer E., Marynen P., Grandchamp B. The 12;21 translo-cation involving TEL Allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996b; 87: 2891–2899
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Seriu T., Bartram C. R., Golub T. R., Reiter A., Miyoshi I., Gilliland D. G., Koeffler H. P. TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia. Leukemia 1997; 11: 1220–1223
   PubMed Web of Science ®Google Scholar
• Raimondi S. C., Shurtleff S. A., Downing J. R., Rubnitz J., Mathew S., Hancock M., Pui C.-H., Rivera G. K., Grosveld G. C., Behm F. G. 12p abnormalities and the TEL gene (ETV6) in childhood acute lymphoblastic leukemia. Blood 1997; 90: 4559–4566
   PubMed Web of Science ®Google Scholar
• Romana S. P., Leconiat M., Poirel H., Marynen P., Brenard O. A., Berger R. Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167–170
   PubMed Web of Science ®Google Scholar
• Stegmaier K., Takeuchi S., Golub T. R., Bohlander S. K., Bartram C. R., Koeffler H. P., Gilliland D. G. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Research 1996; 56: 1413–1417
   PubMed Web of Science ®Google Scholar
• Höglund M., Johansson B., Pedersen-Bjergaard J., Marynen P., Mitelman F. Molecular characterization of 12p abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2. Blood 1996; 87: 324–330
   PubMed Web of Science ®Google Scholar
• Andreasson P., Johansson B., Arheden K., Billstrom R., Mitelman F., HÖGlund M. Deletions of CDKNIB and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Genes Chromosomes and Cancer 1997; 19: 77–83
   PubMed Web of Science ®Google Scholar
• Spirin K. S., Simpson J. F., Takeuchi S., Kawamata N., Miller C. W., Koeffler H. P. p27/Kipl mutation found in breast cancer. Cancer Research 1996; 56: 2400–2404
   PubMed Web of Science ®Google Scholar
• Takeuchi S., Mori N., Koike M., Slater J., Park S., Miller C. W., Miyoshi I., Koeffler H. P. Frequent loss of heterozygosity in region of the KIP1 in non-small cell lung cancer: Evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res 1996b; 56: 738–740
   PubMed Web of Science ®Google Scholar
• Hatta Y., Takeuchi S., Yokota J., Koeffler H. P. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3–13.1 (region of TEL and Kip1 loci) and chromosome 12q23-tecevidence for two new tumour-suppressor genes. British Journal of Cancer 1997; 75: 1256–1262
   PubMed Web of Science ®Google Scholar
• Aïssani B., Bonan C., Sinnett D. Fine physical and transcript mapping of a 1.8Mb region spanning the locus for childhood acute lymphoblastic leukemia on chromosome 12p12.3. 1998, submitted).
   Google Scholar
• Sinnett D., Wagstaff J., Glatt K., Woolf E., Kirkness E. J., Lalande M. High-resolution mapping of the γ-aminobutyric acid receptor subunit β3 and α5 gene cluster on chromosome 15q11-q13, and localization of breakpoints in two Angelman syndrome patients. American Journal of Human Genetics 1993; 52: 1216–1229
   PubMed Web of Science ®Google Scholar
• Bird P. A. CpG islands as gene markers in the vertebrate nucleus. Trends in Genetics 1987; 3: 324–347
   Web of Science ®Google Scholar
• Larsen R, Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics 1992; 13: 1095–1107
   PubMed Web of Science ®Google Scholar
• Watanabe T. K., Shimizu F., Nagata M., Takaichi A., Fugiwara T., Nakamura Y., Takashi E., Hirai Y. Cloning, expression pattern and mapping to 12p13.2-p13.1 of CLAPS3, a gene encoding a novel clathrin-adaptor small chain. Cyrogenetics and Cell Genetics 1996; 73: 214–217
   PubMed Web of Science ®Google Scholar
• Hoornaert I., Marynen P., Baens M. CREBL2, a novel transcript from the chromosome 12 region flanked by ETV6 and CDKNIB. Genomics 1998; 51: 154–157
   PubMed Web of Science ®Google Scholar
• Gyapay G., Morissette J., Vigna A., Dib C., Fizames C., Millasseau P., Marc S., Bemardi G., Lathrop M., Weis-Senbach J. The 1993–1994 genethon human genetic linkage map. Nature Genetics 1994; 7: 246–339
   PubMed Web of Science ®Google Scholar